US5661018AExpiredUtility

Cationic phospholipids for transfection

90
Assignee: UNIV NORTHWESTERNPriority: Mar 29, 1994Filed: Jun 6, 1995Granted: Aug 26, 1997
Est. expiryMar 29, 2014(expired)· nominal 20-yr term from priority
C07F 9/113C07F 9/10C07F 9/65324C12N 15/88A61K 9/1272B82Y 5/00
90
PatentIndex Score
32
Cited by
88
References
2
Claims

Abstract

A novel class of cationic phospholipids and novel method for their synthesis are disclosed. The class of phospholipids comprises phosphotriester derivatives of phosphoglycerides and sphingolipids. It has been unexpectedly found that liposomes comprising one or more of these cationic phospholipids are effective in the lipofection of nucleic acids. These novel phospholipids are particularly attractive because of they are not only effective in lipofection, but are extremely cheap and easy to make.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A liposome-nucleic acid aggregate comprising one or more nucleic acids and one or more liposomes, each liposome comprising one or more cationic phospholipids having the structure: ##STR11## wherein R 4  is a C 1  to about C 24  straight or branched alkyl, alkenyl, or alkynyl chain optionally substituted with a dansyl, NDB, DPH, carbocylclic aromatic, or heterocyclic moiety, or R 4  is a C 1  to about C 6  straight or branched chain ester, aldehyde, ketone, ether, haloalkyl, azidoalkyl, or tetraalkylammonium, R 5  is H or a C 1  to about C 24  straight or branched alkyl, alkenyl, or alkynyl chain optionally substituted with dansyl, NDB, DPH, carbocylclic aromatic, or heterocyclic moiety.   
     
     
       2. A method of transfecting one or more nucleic acids to transform one or more cells comprising contacting the cell or cells with a liposome-nucleic acid aggregate according to claim 1.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.